NOVN - ノバン (Novan Inc.)

NOVNのニュース

   BeiGene Announces Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab  2021/01/11 21:30:00 Business Wire
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BGNE--BeiGene and Novartis enter into a collaboration to develop, manufacture and commercialize tislelizumab, BeiGene's anti-PD-1 antibody.
   Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene  2021/01/11 21:30:00 GlobeNewswire
Agreement expands Novartis Oncology portfolio, adding late-stage PD-1 for monotherapy and potential proprietary PD-1 combinations, driving mid- and…
   Active Pharmaceutical Ingredients (API) Market worth $248.3 billion by 2025 - Leading Key Players are Pfizer Inc. (US), Novartis International AG (Switzerland), Merck & Co. (US)  2021/01/11 14:23:23 OpenPR
According to the new market research report "Active Pharmaceutical Ingredient (API) Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), By Product (Vaccines, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology, CVD) & Region - Global Forecast to 2025",
   Covid-19 Impact On Cell and Gene Therapy Market Next Big Thing | Major Giants: Amgen, Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis, Pfize  2021/01/11 13:33:57 OpenPR
COHERENT MARKET INSIGHTS has added a new report titled Global Cell and Gene Therapy Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. This Cell and Gene Therapy Market
   Covid-19 Impact On Oncology Drugs Market In-Depth Analysis With Key Players Hoffmann-La Roche AG, Novartis International AG, Celgene Corporation, Bristol-Myers Squibb, Pfizer  2021/01/11 13:31:27 OpenPR
COHERENT MARKET INSIGHTS has added a new report titled Global Oncology Drugs Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. This Oncology Drugs Market research report understands the
   Augment the Market Growth of Cell and Gene Therapy Industry By Top Players: Amgen, Biogen, Novartis, Pfizer  2020/11/27 14:30:53 OpenPR
Cell and Gene Therapy market are focused on launching novel cell and gene therapies, in order to treat various diseases and address the critical unmet needs of patients. For instance, in June 2011, Fibrocell Technologies, Inc. received approval from the
   Global Neural Pain Treatment Market 2020-2027:Emerging Opportunities, Revenue Analysis and Growth Projections by GlaxoSmithKline PLC., Novartis AG, Zydus Cadila, Dr. Reddy's Laboratories Ltd, Amneal Pharmaceuticals LLC, Fresenius SE & Co. KGaA  2020/11/27 14:24:59 OpenPR
According to the latest report published by Data Bridge Market Research, the Neural Pain Treatment Market is anticipated to grow at a steady pace over the forecast period 2020 – 2027. The report sheds light on the various trends and
   Oncology Drugs Market Emerging Trend by 2027 | Hoffmann-La Roche AG, Novartis International AG, Celgene Corporation  2020/11/27 14:20:54 OpenPR
Cancer is one of the deadliest disease with less chance of survival as the disease progresses. International Agency for Research on Cancer published GLOBOCAN 2018 report, which estimates cancer incidence and mortality rate. This report focus on geographic variability of
   Over-the-counter Drugs Market Report 2020 - Alkem Laboratories Limited, GlaxoSmithKline Plc., Boehringer Ingelheim GmbH, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Johnson and Johnson Inc., Pfizer, Inc., Novartis AG, Merck KGaA, Sun Pharmaceutical Industr  2020/11/27 12:53:12 OpenPR
An informative study on the Over-the-counter Drugs Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries
   Why Flu Vaccine Market Trending in 2020? Know COVID-19 Impact on Growth and Forecast Research till 2027 Sanofi-pasteur, Novartis, GSK, Abbott  2020/11/27 12:42:05 OpenPR
The global business analytical report titled Flu Vaccine market has recently been published by Healthcare Intelligence Markets to its extensive database. The global Flu Vaccine market is examined on the basis of technological advancements and recent trends of the Flu
   Cold and Flu Drugs Market Will Hit Big Revenues In Future | Biggest Opportunity Of 2025| Bayer, GlaxoSmithKline, Novartis  2020/11/24 15:48:11 OpenPR
The Cold and Flu Drugs market 2020 report analyses global acceptance of trends, future growth potential, key drivers, limitations, opportunities, and best practices that are taken place in market. The report also examines growth potential, market sizes and revenue forecasts
   Hydroxychloroquine Market - Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals Novartis International AG  2020/11/24 12:28:55 OpenPR
An informative study on the Hydroxychloroquine Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries like
   Novartis lance un programme de rachat d'actions pour 2,5 milliards  2020/11/24 07:35:42 La Libre
L'entreprise pharmaceutique suisse Novartis lance mardi et jusqu'à mi-2021 un nouveau programme de rachat d'actions portant sur 2,5 milliards de dollars, à l'occasion de sa journée dédiée aux investisseurs.
   Suisse – Novartis lance un programme de rachat d’actions  2020/11/24 07:14:09 Tribune de Genève
Novartis lance ce mardi et jusqu’à mi-2021 un nouveau programme de rachat d’actions portant sur 2,5 milliards de dollars, à l’occasion de sa journée dédiée aux investisseurs.
   Suisse: Novartis lance un programme de rachat d’actions  2020/11/24 07:14:09 24heures
Novartis lance ce mardi et jusqu’à mi-2021 un nouveau programme de rachat d’actions portant sur 2,5 milliards de dollars, à l’occasion de sa journée dédiée aux investisseurs.

calendar